Medicare Enrolled
Dr. Mathew Alias, D.O.
Neurology · Morristown, NJ
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Alias from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Alias?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Alias
Dr. Mathew Alias is a neurology specialist in Morristown, NJ, with 18 years of NPI registration. Based on federal Medicare data, Dr. Alias performed 6,808 Medicare services across 929 unique beneficiaries.
Between the years covered by Open Payments, Dr. Alias received a total of $13,310 from 95 pharmaceutical and/or device companies across 934 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Alias is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 11% volume in NJ
$13,310 industry payments
Medicare Practice Summary
Medicare Utilization ↗6,808
Medicare services
Top 11% in NJ for neurology
929
Unique beneficiaries
$22
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~378 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
5,710 | $5 | $7 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
449 | $102 | $145 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
223 | $133 | $190 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
127 | $66 | $103 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
89 | $147 | $193 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
56 | $111 | $142 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
44 | $129 | $207 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
41 | $68 | $86 |
| New patient office visit, complex (60-74 min) | 29 | $190 | $253 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
27 | $102 | $130 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
13 | $163 | $255 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$13,310
Total received (2018-2024)
Avg $1,901/year across 7 years
Top 21% in NJ for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
95
Companies
934
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,089 (98.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$222 (1.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,758
2023
$2,117
2022
$2,065
2021
$1,979
2020
$1,483
2019
$2,171
2018
$1,738
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$384
Celgene Corporation
$158
Lundbeck LLC
$120
TG Therapeutics, Inc.
$119
PFIZER INC.
$106
Novartis Pharmaceuticals Corporation
$102
Neurocrine Biosciences, Inc.
$96
Teva Pharmaceuticals USA, Inc.
$90
UCB, Inc.
$70
Biogen, Inc.
$69
Lilly USA, LLC
$67
CSL Behring
$61
AstraZeneca Pharmaceuticals LP
$48
Alexion Pharmaceuticals, Inc.
$36
Eisai Inc.
$35
EMD Serono, Inc.
$32
Amneal Pharmaceuticals LLC
$31
GE HEALTHCARE
$29
Aucta Pharmaceuticals, Inc.
$23
ARGENX US, INC.
$19
Vanda Pharmaceuticals Inc.
$18
Genentech USA, Inc.
$17
SK Life Science, Inc.
$15
Otsuka America Pharmaceutical, Inc.
$13
Top 3 companies account for 37.6% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$1,173
ABBVIE INC.
$813
Biogen, Inc.
$793
Teva Pharmaceuticals USA, Inc.
$748
UCB, Inc.
$563
AbbVie Inc.
$546
Allergan, Inc.
$478
Sunovion Pharmaceuticals Inc.
$451
Celgene Corporation
$426
Lundbeck LLC
$419
PFIZER INC.
$402
Supernus Pharmaceuticals, Inc.
$394
Amgen Inc.
$388
Medtronic USA, Inc.
$372
Alexion Pharmaceuticals, Inc.
$295
Neurocrine Biosciences, Inc.
$287
Allergan Inc.
$283
Lilly USA, LLC
$278
CSL Behring
$219
EMD Serono, Inc.
$208
Eisai Inc.
$205
Genentech USA, Inc.
$177
Acorda Therapeutics, Inc
$142
SK Life Science, Inc.
$138
GE HEALTHCARE
$125
TG Therapeutics, Inc.
$119
Abbott Laboratories
$117
Janssen Pharmaceuticals, Inc
$112
Amneal Pharmaceuticals LLC
$101
Validus Pharmaceuticals LLC
$100
Adamas Pharmaceuticals, Inc.
$97
AstraZeneca Pharmaceuticals LP
$95
GENZYME CORPORATION
$92
Nevro Corp.
$88
ARBOR PHARMACEUTICALS, INC.
$86
UPSHER-SMITH LABORATORIES LLC
$83
W. L. Gore & Associates, Inc.
$81
TG THERAPEUTICS, INC.
$78
Grifols USA, LLC
$70
Scilex Pharmaceuticals Inc.
$64
Avion Pharmaceuticals
$62
Takeda Pharmaceuticals U.S.A., Inc.
$61
Mitsubishi Tanabe Pharma America, Inc.
$60
LivaNova USA, Inc.
$57
CATALYST PHARMACEUTICALS, INC.
$57
JAZZ PHARMACEUTICALS INC.
$56
BOSTON SCIENTIFIC CORPORATION
$48
Boston Scientific Corporation
$47
Bausch Health US, LLC
$46
Currax Pharmaceuticals LLC
$43
Aprecia Pharmaceuticals, LLC
$43
Arbor Pharmaceuticals, Inc.
$43
Kyowa Kirin, Inc.
$43
Impax Laboratories, Inc.
$42
Biohaven Pharmaceutical Holding Company Ltd.
$41
Mallinckrodt LLC
$41
ACADIA Pharmaceuticals Inc
$40
Vanda Pharmaceuticals Inc.
$33
Life Molecular Imaging Ltd
$33
Almatica Pharma LLC
$30
Otsuka America Pharmaceutical, Inc.
$30
Avanir Pharmaceuticals, Inc.
$29
Bayer HealthCare Pharmaceuticals Inc.
$29
BANNER LIFE SCIENCES, LLC
$28
Greenwich Biosciences, Inc.
$28
EISAI INC.
$27
Neurelis, Inc.
$27
Alnylam Pharmaceuticals Inc.
$27
ANI Pharmaceuticals, Inc.
$27
GE HealthCare
$27
Assertio Therapeutics, Inc.
$26
Merz Pharmaceuticals, LLC
$25
Aucta Pharmaceuticals, Inc.
$23
ARGENX US, INC.
$19
Exeltis, USA Inc.
$18
Axsome Therapeutics, Inc.
$17
E.R. Squibb & Sons, L.L.C.
$16
Merz North America, Inc.
$16
IMPEL PHARMACEUTICALS INC.
$16
Piramal Imaging Limited
$16
Banner Life Sciences, LLC
$16
Octapharma USA, Inc.
$15
Akcea Therapeutics, Inc.
$15
Mallinckrodt Enterprises LLC
$15
Virtus Pharmaceuticals LLC
$14
Adlon Therapeutics L.P.
$14
ASSERTIO THERAPEUTICS, Inc.
$14
Biohaven Pharmaceuticals, Inc.
$14
MITSUBISHI TANABE PHARMA AMERICA, INC.
$14
Jazz Pharmaceuticals Inc.
$14
US WorldMeds, LLC
$13
AQUESTIVE THERAPEUTICS, INC.
$13
Alfasigma USA, Inc.
$13
Mylan Specialty L.P.
$12
Sobi, Inc
$12
Top 3 companies account for 20.9% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ACTIVA · ADHANSIA XR · ADUHELM · AFINITOR · AIMOVIG · AJOVY · AMPYRA · AMYVID · ANDEXXA · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Aimovig · Austedo XR · BAFIERTAM · BOTOX · BOTOX THERAPEUTIC · BRILINTA · BRIUMVI · Betaseron · Briviact · CAMBIA · CARDIOFORM Septal Occluder · COMIRNATY · CREXONT · Cambia · Corlanor · DUOPA · Dhivy · ELIQUIS · EMGALITY · Enspryng · Epidiolex · Equetro · FIRDAPSE · Fycompa · GAMMAGARD · GENERAL - DBS · GILENYA · GOCOVRI · GORE CARDIOFORM Septal Occluder · GRALISE · Gamunex-C · General - DBS · Glatiramer Acetate · HETLIOZ · Hizentra · Horizant · INBRIJA · INFINITY · INGREZZA · KESIMPTA · KYNMOBI · LEMTRADA · LEQEMBI · LEVORPHANOL TARTRATE · LYRICA · Leqembi · MAVENCLAD · MAYZENT · MIGRANAL · Mavenclad · Motpoly XR · NAMZARIC · NEURACEQ · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · Neuromodulation Dspsbls and Accs · Nourianz · OCREVUS · ONGENTYS · ONPATTRO · ONZETRA XSAIL · OXTELLAR XR · Ocrevus · Omnia · Ongentys · PANZYGA · PAXLOVID · PLEGRIDY · PONVORY · PURIFIED CORTROPHIN GEL · Ponvory · QULIPTA · RADICAVA · REXULTI · RYTARY · Radicava · SOLIRIS · SPINRAZA · SUNOSI · SYMPAZAN · Senza · Spritam · Sunosi · TECFIDERA · TEGSEDI · TOSYMRA · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · VALTOCO · VNS Therapy · VRAYLAR · VUMERITY · VYEPTI · VYVGART HYTRULO · Vimpat · WAINUA · XEOMIN · XYREM · XYWAV · Xadago · Xeomin · ZEMBRACE SYMTOUCH · ZEPOSIA · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Neurologists within 10 mi
294
Per 100K population
57.6
County median income
$134,929
Nearest hospital
GREYSTONE PARK PSYCHIATRIC HOSPITAL
4.7 mi
4.7 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Alias is a mixed practice specialist, with above-average Medicare volume (top 11% in NJ), with low-engagement industry engagement, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Alias experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Alias performed 5,710 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Alias receive payments from pharmaceutical companies?
Yes. Dr. Alias received a total of $13,310 from 95 companies across 934 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Alias's costs compare to other neurologists in Morristown?
Dr. Alias's average Medicare payment per service is $22. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Alias) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Morristown
Browse neurologists in Morristown ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in NJ
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in NJ
Which NJ neurologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Biogen, Inc. Payments to Doctors
See all physicians who received payments from Biogen, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology